Compare BIO & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HXL |
|---|---|---|
| Founded | 1952 | 1946 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.3B |
| IPO Year | N/A | 1994 |
| Metric | BIO | HXL |
|---|---|---|
| Price | $319.82 | $108.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $339.75 | $88.30 |
| AVG Volume (30 Days) | 270.6K | ★ 1.0M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,893,900,000.00 |
| Revenue This Year | $2.74 | $10.09 |
| Revenue Next Year | $3.20 | $12.33 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $236.73 | $58.20 |
| 52 Week High | $343.12 | $111.01 |
| Indicator | BIO | HXL |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 65.05 |
| Support Level | $296.46 | $81.10 |
| Resistance Level | $325.65 | N/A |
| Average True Range (ATR) | 8.51 | 3.03 |
| MACD | 2.01 | 0.58 |
| Stochastic Oscillator | 96.86 | 76.24 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use primarily in the commercial aerospace and defense markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engine nacelles, and other structures and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.